Aldridge, K.E., Valaninis, G.T. and Saners, C.V. (1988) Comparison of the in Vitro Activity of Ciprofloxacin and 24 Other Antimicrobial Agents against Clinical Strains of Chromobacterium violaceum. Diagnostic Microbiology and Infectious Disease, 10, 31-39.
https://doi.org/10.1016/0732-8893(88)90124-1

has been cited by the following article:

• TITLE: First Case of Chromobacterium violaceum as Urinary Tract Infection Agent in Angola

  AUTHORS: Aleksey Shatalov, Ziv Maianski

  KEYWORDS: Chromobacterium violaceum, Lactose Non-Fermenting, Urine Tract Infection (UTI), Antibiotic Susceptibility

  JOURNAL NAME: Open Journal of Medical Microbiology, Vol.9 No.1, March 25, 2019

  ABSTRACT: Background: Chromobacterium violaceum is a Gram-negative, a facultative anaerobe bacteria producing violacein pigment. C. violaceum is generally present as the normal flora of water and soil. The Urine Tract Infection (UTI) due to C. violaceum is very rare. Until now there was no report from Africa about UTIs caused by C. violaceum. The antimicrobial susceptibility pattern of C. violaceum is very limited due to the rarity of isolation from clinical specimens. Here, we describe the first case of urinary tract infection caused by C. violaceum in Angola. Aim: Our case report was carried out to assess the sensitivity and resistance pattern of C. violaceum as the causative agent of UTI. Results: C. violaceum was sensitive to Amoxicillin/Clavulanic acid, Ceftriaxon, Ciprofloxacin, Doxycycline, Trimethoprim/Sulfamethoxazole, Piperacilin/Tazobactam, Gentamicin, Amikacin, Aztreonam and imipenem. The bacteria showed resistance to Cefuroxime. Conclusion: Here, we report a rare case of complicate urinary tract infection caused by C. violaceum in patient, who was treated successfully with ciprofloxacin for a total duration of 7 days.